Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1986
Preparation for induction of labour of the unfavourable cervix with Foley catheter compared with vaginal prostaglandinI L Thomas, J N Chenoweth, G N Tronc, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1987
Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancerJ H Shepherd, M Granowska, K E Britton, et al.
Nuclear Medicine Communications|March 1, 1989
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinomaM E Crowther, B G Ward, M Granowska, et al.
The Medical Journal of Australia|October 4, 1993
Postpartum haemorrhoids--evaluation of a cooling device (Anurex) for relief of symptomsI L Thomas, M Erian, D Sarson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1990
Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigenG T Layton, P L Devine, J A Warren, et al.
British Journal of Cancer|June 1, 1993
Monoclonal antibodies reacting with the MUC2 mucin core proteinP L Devine, M A McGuckin, G W Birrell, et al.
Cancer Research|November 1, 1991
The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acidP L Devine, B A Clark, G W Birrell, et al.
Gynecologic Oncology|October 5, 2001
Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancerA Obermair, S Hagenauer, D Tamandl, et al.
Breast Cancer Research and Treatment|June 1, 1995
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerP L Devine, M A Duroux, R J Quin, et al.
Biochemical and Biophysical Research Communications|July 31, 1991
Production of MUC1 and MUC2 mucins by human tumor cell linesP L Devine, G T Layton, B A Clark, et al.
Pageof 7